Document Detail


The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men.
MedLine Citation:
PMID:  20534765     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: During testosterone (T) therapy, T is partly converted to 17beta-estradiol (E2) and 5alpha-dihydrotestosterone (DHT). Effects of age, testosterone dose, and body composition on total and free E2 and DHT levels are unknown.
OBJECTIVE: We evaluated age and dose-related differences in E2 and DHT levels in response to graded doses of testosterone enanthate in young and older men.
METHODS: Fifty-one young (aged 19-35 yr) and 52 older (aged 59-75 yr) men completed treatment with monthly injections of a GnRH agonist plus randomly assigned weekly doses of testosterone enanthate (25, 50, 125, 300, or 600 mg) for 5 months.
RESULTS: During testosterone administration, total and free E2 levels increased dose-dependently (dose effect, P<0.001) in both young and older men. Total and free E2 levels and E2:T ratios during T administration were higher in older than young men, but age-related differences in free E2 and free E2:T ratios were not significant after adjusting for testosterone levels, percentage fat mass, and SHBG. DHT levels and DHT:T ratios were dose-related but did not differ between young and older men. Mechanistic modeling of free hormone data revealed that the conversions of T to E2 and DHT were both consistent with saturable Michaelis-Menten kinetics. The in vivo Km values were estimated to be 1.83 nm for aromatase and 3.35 nm for 5alpha-reductase, independent of age. The Vmax parameter for E2 was 40% higher in older men than younger men, but Vmax for DHT was not significantly different between age groups.
CONCLUSIONS: During im testosterone administration, E2 and DHT levels exhibit saturable increases with dose. The rate of whole body aromatization is higher in older men, partly related to their higher percentage fat mass, SHBG, and testosterone levels.
Authors:
Kishore M Lakshman; Beth Kaplan; Thomas G Travison; Shehzad Basaria; Philip E Knapp; Atam B Singh; Michael P LaValley; Norman A Mazer; Shalender Bhasin
Related Documents :
22250625 - Head lice infestation in schoolchildren and related factors in mafraq governorate, jordan.
16042365 - Associated hormonal declines in aging: dheas.
18559915 - Inverse association of testosterone and the metabolic syndrome in men is consistent acr...
22042695 - Population pharmacokinetics of recombinant factor viii: the relationships of pharmacoki...
1450595 - Free radicals and aging of the skin.
1489485 - Enhancement of s-antigen and its mrna in the irides of uveitic patients.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural     Date:  2010-06-09
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  95     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-05     Completed Date:  2010-08-24     Revised Date:  2011-08-03    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3955-64     Citation Subset:  AIM; IM    
Affiliation:
Division of Endocrinology, Diabetes and Nutrition, Boston Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies, Boston University School of Medicine, Boston Medical Center, 670 Albany Street, Second Floor, Boston, Massachusetts 02118, USA. Kishore.Lakshman@bmc.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Aged
Analysis of Variance
Body Composition
Chromatography, Liquid
Dihydrotestosterone / blood*
Dose-Response Relationship, Drug
Estradiol / blood*
Humans
Male
Middle Aged
Patient Selection
Sex Hormone-Binding Globulin / metabolism
Tandem Mass Spectrometry
Testosterone / administration & dosage,  analogs & derivatives*,  metabolism*
Grant Support
ID/Acronym/Agency:
1 UO1AG14369/AG/NIA NIH HHS; 1R01AG31206/AG/NIA NIH HHS; 5P30 AG31679/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Sex Hormone-Binding Globulin; 315-37-7/testosterone enanthate; 50-28-2/Estradiol; 521-18-6/Dihydrotestosterone; 58-22-0/Testosterone
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during th...
Next Document:  Higher high-density lipoprotein cholesterol in African-American women with polycystic ovary syndrome...